Hydroxyprogesterone Caproate
NDC 47335-037
Product Information
Hydroxyprogesterone Caproate is a ANDA-approved product labeled by Sun Pharmaceutical Industries, Inc.. This medication is used in women who are pregnant with a single baby, and who have delivered a baby too early (preterm) in the past. It is supplied as a product. This product entry covers the primary NDC 47335-037 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 47335-037?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- HYDROXYPROGESTERONE CAPROATE (UNII: 276F2O42F5)
- HYDROXYPROGESTERONE (UNII: 21807M87J2) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- BENZYL BENZOATE (UNII: N863NB338G)
- CASTOR OIL (UNII: D5340Y2I9G)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1087964 - HYDROXYprogesterone caproate 250 MG/ML Injectable Solution
- RxCUI: 1087964 - hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution
* Please review the full disclaimer at the bottom of this page.